National Kidney Registry Welcomes David Serur, MD and Marian Charlton, RN, CCTC, to Its Medical Board

NEW YORK, NY--(Marketwire - October 16, 2007) - The National Kidney Registry, a non-profit organization dedicated to improving the lives of those facing kidney failure, is pleased to announce the addition of David Serur, MD, and Marian Charlton, RN, CCTC, to its Medical Board. Dr. Serur is currently the Medical Director of the Kidney/Pancreas Transplant Program at The Rogosin Institute in New York City. He is Associate Professor of Medicine and Surgery at New York Presbyterian Weill Cornell. Marian Charlton is the Living Donor Transplant Coordinator at The Rogosin Institute. Ms. Charlton has over twenty years experience working in transplantation.

"We are honored to have Dr. Serur and Ms. Charlton join our Medical Board. As an adult nephrologist from a leading medical center, Dr. Serur fills an important void on our medical board as does Ms. Charlton, who will provide the valuable perspective of a transplant coordinator from a major hospital who is on the front lines every day working with living donors. Having such strong representation and support on our board from NewYork-Presbyterian Hospital will accelerate our ability to deliver on our mission," said Garet Hil, founder of the National Kidney Registry.

"We are interested in expanding the options for people seeking living donor transplants and believe the National Kidney Registry will be able to help us make significant progress in this area," said Dr. Serur.

"Our living donor transplant program is well-established, and we are seeking opportunities to increase the number of transplants we do. We think it will be beneficial to work with the National Kidney Registry to find more matches," noted Ms. Charlton.

About the National Kidney Registry

The National Kidney Registry is a nonprofit organization registered under the laws of the State of New York. The mission of the National Kidney Registry is to save and improve the lives of people facing kidney failure by increasing the quality, speed, and number of living donor transplants in the world.

About NewYork-Presbyterian Hospital

NewYork-Presbyterian Hospital is one of the most comprehensive university hospitals in the world, with leading specialists in every field of medicine. We are composed of two renowned medical centers, NewYork-Presbyterian Hospital/Columbia University Medical Center and NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and affiliated with two Ivy League medical institutions, Columbia University College of Physicians & Surgeons and Weill Medical College of Cornell University.

NewYork-Presbyterian Hospital was voted the best hospital in the greater New York area in New York Magazine's 2006 Best Hospitals survey. It was also voted number one in pediatrics, psychiatry, cancer care, obstetrics and gynecology, and neurology/neuroscience. NewYork-Presbyterian Hospital is also ranked higher in more specialties than any other hospital in the New York area by U.S.News & World Report™. In 2007, it earned us a rank of 6th in the nation on the U.S.News Honor Roll of America's Best Hospitals for the second year in a row.

The Hospital's Transplantation Institute is the New York region's flagship center for kidney transplantation in adults and children, providing the most advanced surgical techniques and innovative immunosuppressive therapy available in the United States. The successful track record of our kidney transplant programs is unsurpassed and spans decades. The Institute combines outstanding programs at NewYork-Presbyterian/Columbia University Medical Center and NewYork-Presbyterian/Weill Cornell, each individually recognized for its pioneering research and depth of clinical expertise in kidney transplantation.

About The Rogosin Institute

The Rogosin Institute is a not-for-profit institution for medical research and treatment in kidney disease (including dialysis and transplantation) and cardiovascular disease related to cholesterol and other lipid abnormalities. The Rogosin Institute also has extensive research programs in diabetes, cancer, endotoxemia, and telemedicine.